Can controlled substances become the new standard of care for psychiatric disorders?
First-line therapies such as Zoloft (sertraline hydrochloride) and benzodiazepines such as diazepam also come with boxed warnings due to the…
By
mental health conditions
Latest in
mental health conditions
Partner content
Global post-traumatic stress disorder market set to reach US$1.2 billion by 2028, says GlobalData
Post-traumatic stress disorder (PTSD) is a psychiatric disorder that occurs in those who have experienced or witnessed a traumatic event.…
UK Government invests £35m into researching adolescent mental health
The UK Government has launched a research project into understanding the causes of mental health problems in teenagers and young…
By
ViiV unveils emotional challenges related to HIV ART treatment
GSK’s ViiV Healthcare has presented results from its Positive Perspectives study examining the emotional challenges and burden of human immunodeficiency…
By
Takeda and Lundbeck’s Trintellix approved in Japan for depression
Takeda has announced that its drug Trintellix (vortioxetine) has been approved by the Japanese Ministry of Health, Labour and Welfare…
By
Can sleep disruptions lead to Alzheimer’s disease?
An October 2018 study published in the European Journal of Epidemiology by Bokenberger and colleagues found that previous history of…
By
World Alzheimer’s Day, #LetsTalkAboutDementia
A feeling of lack of understanding can be overwhelming for dementia patients and their caregivers and directly impacts the effectiveness…
By
Janssen’s esketamine reduces symptoms in suicidal depression
Johnson & Johnson subsidiary Janssen has announced its esketamine nasal spray reduced depressive symptoms in adult major depressive disorder patients…
By